@regretchard01
active 3 hours, 33 minutes ago
Efficient evaluation with an early surrogate endpoint, taking into account the process of disease evolution, may not only clarify inconsistent or underpowered results but also provide a new insight into the exploration of a new antiviral therapy for treating COVID-19 patients.
We assessed the dynamics of COVID-19 disease spectrum, […] View